Category: Uncategorized

Proactive Investors Interview – Algernon Pharmaceuticals Gains Approval for Phase 1 Clinical Study of DMT for Treatment of Stroke
Streetwise Reports – Will Pharma Co. Keep Pushing Higher After Full Data Set Released on Lung Disease Study?
Expert Investor Rates Algernon Pharmaceuticals as an Immediate Buy
Proactive Investors Interview – Algernon Pharmaceuticals Releases Positive Data from Study on Ifenprodil for IPF and Chronic Cough
Streetwise Reports – Hedge Fund Doubles Position in Biotech Co.
MedicalGold.ca – Algernon Rapidly Advances Clinical Trials For Two Lead Programs
Research Capital Corporation – Additional Phase 2a Analysis by a Chronic Cough KOL
Pulmonary Fibrosis News – NP-120, Potential IPF Treatment, Stabilizes Lung Function in Trial
Streetwise Reports – Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity
Research Capital Corporation – Breathing Easier – Liftoff! – IPF Phase 2a Data Hits

About Us

Get the skills, guidance, and resources you need to make a big difference in your contact center operations that can lead to a big difference

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.